AZD8055 Is a Potent, Selective, and Orally Bioavailable...

Cancer Research 2010 / 01 Vol. 70; Iss. 1

AZD8055 Is a Potent, Selective, and Orally Bioavailable ATP-Competitive Mammalian Target of Rapamycin Kinase Inhibitor with In vitro and In vivo Antitumor Activity

Chresta, C. M., Davies, B. R., Hickson, I., Harding, T., Cosulich, S., Critchlow, S. E., Vincent, J. P., Ellston, R., Jones, D., Sini, P., James, D., Howard, Z., Dudley, P., Hughes, G., Smith, L., Mag
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
70
Language:
english
Journal:
Cancer Research
DOI:
10.1158/0008-5472.can-09-1751
Date:
January, 2010
File:
PDF, 932 KB
english, 2010
Conversion to is in progress
Conversion to is failed